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COCHRANE REVIEWS
Cochrane Collaborative Review Group on Peripheral Vascular Diseases:
Review Abstracts
Introduction Abstracts
The following abstracts are part of an ongoing series Abstract. Surgery versus thrombolysis for acute limb
ischaemia: initial managementof articles produced by the Cochrane Collaborative
Review Group on Peripheral Vascular Diseases, which D. C. Berridge, D. Kessel and I. Robertson
Date of most recent substantive amendment: 1 June 2000is part of the Cochrane Collaboration. The reviews are
published in full on The Cochrane Library, a quarterly
electronic journal available on CD-ROM and via the
Internet. The electronic format allows Cochrane re- Background
views to accommodate new data as they become avail-
able, making the library a consistently up-to-date Peripheral arterial thrombolysis has become es-
source of information over time. tablished as a useful adjunct in the management of
The abstracts appearing on the Cochrane Library peripheral arterial ischaemia. Much has been learnt
are now presented in a different, simpler, less scientific about indications, risks and benefits using this tech-
format than the abstracts presented here to permit nique, although data from randomised controlled stud-
greater accessibility to the public. However, the sub- ies are not extensive. The optimal initial management
stance of both versions is the same. Review abstracts of the acutely ischaemic leg needs to be determined.
on Cochrane reviews will be indexed on MedLine in
the near future.
If you are interested in writing a Cochrane review
Objectivesor contributing to the activities of the Cochrane Peri-
pheral Vascular Diseases Group please contact:
To determine whether surgery or thrombolysis should
Professor F. G. R. Fowkes be the preferred option in the initial treatment of acute
Cochrane Collaborative Review Group on limb ischaemia.
Peripheral Vascular Diseases
Public Health Sciences
University of Edinburgh
Search strategyTeviot Place
Edinburgh EH8 9AG
All publications describing (or which might describe)Tel. +44 (0) 131 650 3220
randomised controlled trials of surgery versus throm-Fax. +44 (0) 131 650 6904
bolysis for initial management of acute limb ischaemia
Any comments or criticisms on these Cochrane re- were sought using the search strategy described by
views/abstracts should be made through the com- the Cochrane Review Group on Peripheral Vascular
ments/criticisms facility on the Cochrane Library, or Diseases. This strategy includes hand searching of
by contacting the group at the above address. relevant medical journals and extensive MEDLINE
and EMBASE searches. In addition, trials have been
identified from searches of references included in those
trials already retrieved. Additionally, reference lists of
papers resulting from this search were reviewed.
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Selection criteria Abstract. Intravenous fluids for abdominal aortic
surgery
All randomised studies comparing thrombolysis and P. J. Whatling
Date of most recent substantive amendment: 15 May 2000surgery in the initial management of acute limb isch-
aemia.
BackgroundData collection and analysis
Surgery on the abdominal aorta for aneurysmal andTrial quality was assessed and data were extracted
occlusive disease is a major undertaking, which re-independently by all three reviewers.
quires intensive support and fluid management. Blood
products are often used, but the major fluid re-
placement is with crystalloids or colloids. There hasMain results
been controversy for many years over which fluid is
optimal, and a number of studies have examined thisFive trials involving 1283 patients were included in
subject, without any systematic review.the review. One trial showed that patients with acute
lesions of less than 7 days’ duration who had throm-
bolysis had a significantly increased survival at 1 year
compared to those that had had initial surgery [84% Objectives
vs. 58%, p=0.01; Odds ratio (95% CI) 0.28 (0.13,0.63)].
This was largely associated with a reduced level of in- The objective of this review was to determine the
hospital cardio-pulmonary complications. effectiveness of different non-blood replacement fluids
In another trial patients with lesions of less than 14 used in surgery on the abdominal aorta, with a view
days’ duration fared better with initial lysis, showing to identifying the optimal fluid for use in such surgery.
reduced amputation and death rates at 6 months
[15.3% vs. 37.5%; p=0.001; Odds ratio (95% CI) 0.29
(0.12,0.72)], compared to patients given initial surgery. Search strategy
Analysis of the same trial at 1 year, however, revealed
that native vessel thromboses had a more favourable All publications describing (or which might describe)
outcome with initial surgery, largely due to continuing randomised controlled trials of non-blood replacement
ischaemia in the lytic group [64% vs. 35%; p<0.0001; fluids in abdominal aortic surgery were sought using
Odds ratio (95% CI) 3.26 (1.96,5.52)]. the search strategy described by the Cochrane Review
A third trial showed that treatment of bypass graft Group on Peripheral Vascular Diseases. This strategy
thromboses, less than 14 days old, with initial throm- includes hand searching of relevant medical journals
bolysis resulted in a reduced amputation rate (15% and extensive MEDLINE and EMBASE searches. In
vs. 47%; p=0.05). However, overall, one-year results addition, trials have been identified from searches of
revealed that thrombolysis of thrombosed grafts was references included in those trials already retrieved.
associated with a higher level of continued ischaemia
[73% vs. 50%; p=0.010; Odds ratio (95% CI) 2.72 (1.27,
5.80)]. Selection criteria
Randomised controlled trials assessing the effects ofReviewers’ conclusions
one or more specific non-blood fluids used for re-
placement therapy in operations on, and confined to,A universal initial treatment with either surgery or
the abdominal aorta.thrombolysis cannot be advocated on the available
evidence. There is no overall difference in limb salvage
or death at 1 year between initial surgery and initial
thrombolysis. Thrombolysis may, however, be as- Data collection and analysis
sociated with a higher risk of ongoing limb ischaemia,
and a higher overall risk of haemorrhagic com- Data were extracted to pre-prepared tables and then
entered into Review Manager software where stat-plications including stroke. The higher risk of com-
plications needs to be balanced against the risks of istical analysis and descriptive subjective analyses
were performed.surgery in the individual patient.
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Main results measure significantly more than any other across a
range of outcome measures. However, each trial com-
Nine trials, involving 412 patients, were included. pared different fluids, and each fluid has not been
Patients undergoing aortic surgery had various physio- compared against all others. The death rate in these
logical parameters measured before and after their studies was 2.9% (12 patients).
operation (cardiac, respiratory, biochemical, haemato-
logical and protein). Ten fluids were studied: Ringer
lactate, 5% dextrose in Ringer lactate, 5% dextrose in
Reviewers’ conclusions0.45% saline, 5% dextrose in water, 1.8% saline, human
albumin solution in Ringer lactate, human albumin
Further studies are required, with sufficient samplesolution in water, 5% dextrose with human albumin
size and power, to draw any further conclusions. Theresolution, Dextran 60, Hetastarch. Patients were ran-
are no studies examining the effects of combinationdomised to fluid type. This review demonstrates that
no single fluid has been shown to affect any outcome fluid therapy.
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